NIH-funded research R01 grant

How immune cells in the stomach may drive gastroparesis

Official title: From stomach tissue to cellular mechanisms: unraveling the role of mononuclear phagocytes in the pathophysiology of gastroparesis

Funded at University of California, San Diego · NIH-11144478 · Data updated 2026-11-12

This work looks at whether specific immune cells in the stomach differ in people with gastroparesis and how those differences link to delayed emptying and symptoms.

More Gastroparesis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startSeptember 30, 2021
Project endJuly 31, 2026
Funding year2025
Award (this year)$395,000
NIH project number5R01DK131500-06
Project IDNIH-11144478 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults diagnosed with gastroparesis who can provide clinical information and agree to stomach biopsy or tissue sampling at the study site.

Less likely to help

People without gastroparesis or those unable or unwilling to undergo endoscopic tissue sampling are unlikely to directly benefit from this project.

What this research studies

Researchers will examine stomach tissue from people with and without gastroparesis using advanced single-cell methods (including mass cytometry) to map immune cell types and states. They will compare immune cells in both the stomach mucosa and muscularis layers and measure how cell changes relate to gastric emptying and symptom severity. The team will analyze numbers and function of mononuclear phagocytes (a group that includes macrophages and related cells) to identify dysregulated populations. Results aim to point to cellular mechanisms that could become targets for new treatments.

Why it matters

Potential benefit: If successful, this work could identify immune cell targets that lead to new therapies to reduce nausea, pain, and delayed gastric emptying in gastroparesis patients.

How similar studies have gone: Preliminary data suggest immune cell differences in gastroparesis, but translating these cellular findings into effective treatments is a new and still unproven approach.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Idoyaga, Juliana — University of California, San Diego
  • Study coordinator: Idoyaga, Juliana

Related research

Other NIH-funded projects on the same topics.

  • New England Gastroparesis Consortium: Neurobiology of Gastroparesis

    A national project to learn about gastroparesis in children and adults by creating a registry and gathering information from patients to understand symptoms, quality of life, and disease progression.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11583186

  • Pediatric and Young Adult Gastroparesis Registry and Disease Course

    This project follows children, teens, and young adults with symptoms of gastroparesis to learn how their symptoms change over time and what factors are tied to different disease patterns.

    NIH research Texas Tech University Health Sciences Center at El Paso · El Paso, United States · NIH-11575566

  • Pediatric gastroparesis: building a nationwide patient registry

    This grant funds a national registry to study gastroparesis and similar tummy problems in children and teens, with the goal of better understanding how the condition affects their daily lives.

    NIH research Baylor College of Medicine · Houston, United States · NIH-11567122

  • Gut-resident macrophages and gastric function in gastroparesis

    A study in people with gastroparesis to understand how gut macrophages affect stomach movement and gut barrier health, with the hope of finding new ways to treat the condition.

    NIH research University of Nevada Reno · Reno, United States · NIH-11430037

  • Gastric electrical stimulation for stomach pain in gastroparesis

    A new approach tests how adjusting a stomach-stimulating implant may reduce pain for people with gastroparesis.

    NIH research University of Louisville · Louisville, United States · NIH-11416260

  • Peptide therapies for gastroparesis in diabetes

    A new peptide-based treatment is being tested to help people with gastroparesis linked to diabetes by improving stomach emptying and reducing inflammation.

    NIH research Cga Therapeuticals Incorporated · San Diego, United States · NIH-11410020

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.